Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
Dr Keith W. Hamilton joins Ethics Talk to discuss his article, coauthored with Dr George Maliha, Keith Robert Thomas, and Mary Ellen Nepps: “How Might Antibiotic Stewardship Programs Influence Clinicians’ Autonomy and Organizations’ Liability?”
Physicians need to carefully explain the difficult medical realities of carrying a fetus with severe congenital abnormalities to term but then follow the wishes of a religious family who ask for reasonable medical care.
Physicians need to carefully explain the difficult medical realities of carrying a fetus with severe congenital abnormalities to term but then follow the wishes of a religious family who ask for reasonable medical care.